Pfizer's Stock Declines by -3.03% on November 13, 2024, Underperforms Sector by -1.77%

Pfizer ., a leading pharmaceutical and drug company, saw a decline of -3.03% in its stock on November 13, 2024. This drop was reflected in the stock's performance today, as it underperformed the sector by -1.77%. The stock touched an intraday low of Rs 5135, a decrease of -3.28%.

According to MarketsMOJO, a financial analysis and research platform, the stock call for Pfizer . is 'Hold'. This recommendation is based on the stock's current performance and market trends.

In terms of moving averages, Pfizer .'s stock is currently higher than its 200 day moving average, but lower than its 5 day, 20 day, 50 day, and 100 day moving averages. This indicates a mixed trend in the stock's performance.

In comparison to the overall market, Pfizer .'s stock has underperformed. On the day of November 13, 2024, the stock's performance was -3.20%, while the Sensex's performance was -0.67%. Over the past month, Pfizer .'s stock has also seen a decline of -10.47%, while the Sensex's performance was -3.98%.

Overall, Pfizer .'s stock has seen a decline in its performance, with a 'Hold' recommendation from MarketsMOJO. Investors should keep an eye on the stock's moving averages and market trends for a better understanding of its future performance.